Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,454 papers from all fields of science
Search
Sign In
Create Free Account
bilastine
Known as:
p-(2-(4-(1-(2-Ethoxyethyl)-2-benzimidazolyl)piperidino)ethyl)-alpha-methylhydratropic Acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Benzimidazoles
Piperidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
A. Leceta
,
A. Sologuren
,
R. Valiente
,
C. Campo
,
L. Labeaga
Drugs in Context
2017
Corpus ID: 11211907
Background Bilastine is a safe and effective commonly prescribed non-sedating H1-antihistamine approved for symptomatic treatment…
Expand
2015
2015
Bilastine: an environmental risk assessment
M. L. Lucero
,
A. Peither
,
F. Ledo
Drug and chemical toxicology (New York, N.Y. )
2015
Corpus ID: 2863791
Abstract Context: Bilastine is a new oral selective, non-sedating histamine H1 antagonist for the symptomatic treatment of…
Expand
2014
2014
Bilastine as a Potential Treatment in Allergic Rhinitis
K. Kowal
,
L. Dubuske
American Journal of Rhinology & Allergy
2014
Corpus ID: 28875953
Background Allergic rhinitis is a very frequent disease. H1 antihistamines have been used for treatment of allergic rhinitis for…
Expand
2014
2014
Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
L. Valeyrie‐Allanore
,
M. Mockenhaupt
,
+8 authors
S. le Gouvello
Clinical and Translational Allergy
2014
Corpus ID: 382988
Background / Objective Prior use of “lymphocyte transformation test” (LTT) suggested that it was less often positive in Stevens…
Expand
2014
2014
Molecular determinants responsible for sedative and non-sedative properties of histamine H₁-receptor antagonists.
Y. Uesawa
,
S. Hishinuma
,
M. Shoji
Journal of Pharmacological Sciences
2014
Corpus ID: 29245693
There is argument whether non-sedative properties of histamine H1-receptor antagonists (antihistamines) are determined by their…
Expand
2012
2012
Effects of Bilastine on T-wave Morphology and the QTc Interval
C. Graff
,
J. Struijk
,
Jørgen K. Kanters
,
M. P. Andersen
,
E. Toft
,
B. Tyl
Clinical drug investigation
2012
Corpus ID: 22766684
AbstractBackground and Objectives: The International Conference of Harmonisation (ICH) E14 guideline for thorough QT studies…
Expand
Review
2012
Review
2012
Preclinical toxicity profile of oral bilastine
M. L. Lucero
,
J. Arteche
,
E. Sommer
,
A. Casadesus
Drug and chemical toxicology (New York, N.Y. )
2012
Corpus ID: 23279474
As part of the bilastine development program, and as mandated by regulatory authorities, several studies were performed with oral…
Expand
2011
2011
Bilastine for the relief of allergy symptoms.
B. Rada
,
J. Perea
,
A. Hormigós
2011
Corpus ID: 196376426
Bilastine is a potent inhibitor of the histamine H1 receptor. It was recently approved in 28 countries of the European Union for…
Expand
Review
2011
Review
2011
Bilastine for the relief of allergy symptoms.
B. Sádaba Díaz de Rada
,
J. R. Azanza Perea
,
A. Gomez-Guiu Hormigos
Drugs of Today
2011
Corpus ID: 23577995
Bilastine is a potent inhibitor of the histamine H1 receptor. It was recently approved in 28 countries of the European Union for…
Expand
Review
2009
Review
2009
Chapter 15 – Antihistamines (H1 Receptor Antagonists)
G. Walsh
2009
Corpus ID: 79602101
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE